“ISRG Stock Takes a Tumble Despite Crushing Q4 Earnings and Rockin’ Procedures – What Gives?”
Delightfully Offbeat: Analyzing ISRG’s Fourth Quarter Results Setting the Stage Picture this: the stage is set, and the curtains are drawn. ISRG’s fourth-quarter results are in, and the numbers are looking good. The demand for procedures is healthy, and higher pricing is boosting procedure sales. It’s a scene straight out of a success story, and…